Cargando…

Time from first presentation in primary care to treatment of symptomatic colorectal cancer: effect on disease stage and survival

BACKGROUND: British 5-year survival from colorectal cancer (CRC) is below the European average, but the reasons are unclear. This study explored if longer provider delays (time from presentation to treatment) were associated with more advanced stage disease at diagnosis and poorer survival. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murchie, P, Raja, E A, Brewster, D H, Campbell, N C, Ritchie, L D, Robertson, R, Samuel, L, Gray, N, Lee, A J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119995/ https://www.ncbi.nlm.nih.gov/pubmed/24992583 http://dx.doi.org/10.1038/bjc.2014.352

Ejemplares similares

Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
por: Wishart, G C, et al.
Publicado: (2008)

Modifiable and fixed factors predicting quality of life in people with colorectal cancer
por: Gray, N M, et al.
Publicado: (2011)

Rural and urban differences in stage at diagnosis of colorectal and lung cancers
por: Campbell, N C, et al.
Publicado: (2001)

Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial
por: Murchie, P, et al.
Publicado: (2010)

Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas
por: Robertson, R, et al.
Publicado: (2004)

The influence on survival of delay in the presentation and treatment of symptomatic breast cancer
por: Richards, M A, et al.
Publicado: (1999)

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
por: Catalano, V, et al.
Publicado: (2009)

Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003–2007
por: Brewster, D H, et al.
Publicado: (2011)

Breast cancer awareness and barriers to symptomatic presentation among women from different ethnic groups in East London
por: Forbes, L J L, et al.
Publicado: (2011)

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
por: Kelly, Deanna L, et al.
Publicado: (2013)

Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?
por: Woodman, C B J, et al.
Publicado: (2001)

Predictors of survival after hepatic resection among patients with colorectal liver metastasis
por: Wang, X, et al.
Publicado: (2007)

Symptomatic Pectus Excavatum in Seniors: An Exploratory Study on Clinical Presentation and Incidence in Daily Practice
por: Winkens, Ron A. G., et al.
Publicado: (2013)

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
por: Soong, R, et al.
Publicado: (2009)

Symptomatic Colorectal Cancer Is Associated With Stage IV Diagnosis in Two Disparate Populations
por: Fong, Carmen, et al.
Publicado: (2022)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women
por: Coghill, A E, et al.
Publicado: (2011)

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018)

Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study
por: Terhaar sive Droste, Jochim S, et al.
Publicado: (2010)

Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
por: Gusella, M, et al.
Publicado: (2009)

Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status
por: Watkins, D J, et al.
Publicado: (2010)

The UK colorectal cancer screening pilot: results of the second round of screening in England
por: Weller, D, et al.
Publicado: (2007)

Quantifying the influence of water deficit on root and shoot growth in wheat using X-ray Computed Tomography
por: Khalil, A M, et al.
Publicado: (2020)

Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer.
por: Chapman, M. A., et al.
Publicado: (1998)

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK
por: Campbell, H E, et al.
Publicado: (2010)

The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study
por: Libby, G, et al.
Publicado: (2012)

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
por: Wright, J D, et al.
Publicado: (2008)

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
por: Hofheinz, R-D, et al.
Publicado: (2012)

Symptomatic trigeminal neuralgia as the first presentation of acute lymphoblastic leukemia
por: Chaudhuri, Tamojit, et al.
Publicado: (2013)

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease
por: Lutgens, M W M D, et al.
Publicado: (2009)

Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review
por: Mitchell, E, et al.
Publicado: (2008)

Anisohydric sugar beet rapidly responds to light to optimize leaf water use efficiency utilizing numerous small stomata
por: Barratt, Georgina E, et al.
Publicado: (2020)

Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial
por: Okines, A, et al.
Publicado: (2009)

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial
por: Engbersen, M. P., et al.
Publicado: (2021)

Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer: A Population-Based Cohort Study
por: Castelo, Matthew, et al.
Publicado: (2022)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

Innovative estimation of survival using log-normal survival modelling on ACCENT database
por: Chapman, J W, et al.
Publicado: (2013)

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer
por: Ng, K, et al.
Publicado: (2009)

Impact of deprivation and rural residence on treatment of colorectal and lung cancer
por: Campbell, N C, et al.
Publicado: (2002)

Mid-term results of sub-trochanteric valgus osteotomy for symptomatic late stages Legg-Calvé-Perthes disease
por: Emara, Khaled M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_npbpbg4o44cf4de5l30tkfg9qb